Team of Phialogics (from left: Andreas Ernst, acting CEO, CSO; Michael J. Parnham; Andreas von Knethen; Pascal Oromi, CBO; Andreas Weigert. © Phialogics AG

Phialogics AG has got a €600,000 pre-seed financing from German HTGF to validate its approach to rebalance the immune system of people with auto-immune diseases.

Picture: Biovian

The switch from lab-scale to industrial-scale AAV production requires deep ­hands-on expertise in various technological solutions, their limitations, and their ­suitability for GMP large-scale manufacturing. Direct application of lab-scale process leads to expensive ­AAV-based products and unnecessarily laborious industrial processes. The complexity and growing demands for controllable critical quality attributes (CQAs), create a challenging blend.

© pixabay.com/moerschy

European life sciences venture capital company Forbion has raised two oversubscribed funds totalling €1.35 bn.

© Ariceum Therapeutics

German radiopharmaceuticals developer Ariceum Therapeutics has raised a further €22.75m extension of its €25m Series A financing announced in June 2022.

agenX

Genmab and argenx have entered a multiyear collaboration bringing together capabilities to jointly discover, develop and commercialise antibody therapies.

Flow cell. © Adaptyv Biosystems Sàrl

Swiss Adaptyv Biosystems Sàrl has launched two fast-feedback tools that allow cheap, rapid and minaturised validation of AI-designed proteins.

Picture: ©?Northway Biotech

Biomanufacturing?Implementing high-quality process development that considers GMP manufacturing from the start is critical to reducing costs and timeline disruptions associated with raw material supply chain insecurity, adhering to regulatory compliance, and avoiding process re-design at a later stage.

© NCI

Ultrasound that switches cancer drug on could significantly reduce chemotherapy side effects, German researchers found in preclinical studies.

Thin cell-based beefsteak prototype. © Aleph Farms

At the beginning of April, the FAO presented a report entitled "Food safety aspects of cell-based food" to establish safety standards for cell-based proteins.

16-9-Autosampler

Taking samples during bioprocessing is an integral part of quality control. It allows to gather information about culture growth, medium conditions, as well as metabolite or product concentrations. Ideally, sampling should take place regularly and in equal intervals. However, for manual sampling this often involves extra work at night or during weekends. Here, automated sampling is an attractive alternative, freeing up time for other tasks or just a relaxing weekend. The Eppendorf Bioprocess Autosampler is offering exactly that freedom by allowing 24/7 sampling and safe storage of your valuable culture snapshots.